Chandra Daya Investasi Tbk. vs Merck Tbk. — how do they compare? Chandra Daya Investasi Tbk. trades at Rp630 (market cap 79.27T, 25.43M 24h volume), while Merck Tbk. trades at Rp3,860 (market cap 1.7T, 28K 24h volume). The key difference: Chandra Daya Investasi Tbk. is far larger — about 46.6× Merck Tbk.'s market cap, and Chandra Daya Investasi Tbk. is more actively traded (25.43M versus 28K). Which is the better fit depends on your goals.
| CDIA | MERK | |
|---|---|---|
Market Cap | 79.27T | 1.7T |
Volume | 25.43M | 28K |
Lot | 254.3K | 280 |
Turnover | 15.92B | 107.47M |
Average Price | 626.16 | 3,838.25 |
Value | 15.92B | 107.47M |
Indicative Equilibrium Price | 635 | 3,850 |
Indicative Equilibrium Volume | 93.1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Chandra Daya Investasi Tbk. the (Company) was established based on Notarial Deed No. 26 dated February 8, 2023, of Jose Dirma Satria, S.H., M.Kn., Notary in Jakarta. The Company started its commercial operations in 2023. The Company is a subsidiary of PT Chandra Asri Pacific Tbk and belongs to a group of companies owned by PT Barito Pacific Tbk (Barito Pacific Group). Mr. Pajogo Pangestu is the ultimate beneficial owner of the Company.
Read more on CDIA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →